Regeneron Pharmaceuticals Inc.

(REGN) Trade

By |

Profile

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.

Contact Information

Website: www.regeneron.com
Email: manisha.narasimhan@regeneron.com
Main Phone: +1 914 847-7000
Address: 777 Old Saw Mill River Road
State: NY
City / Town: Tarrytown
Country: USA
Postal Code: 10591-6707

Issuer Information

Exchange: NGS
CEO: Leonard S. Schleifer
Employees: 6200
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 377.96 $ 2.24 (0.60%)
Last Price 377.96 Change $ 2.24 Change % 0.60 Tick N/A
Bid 375.50 Bid Size 100.00 Ask 386.00 Ask Size 100.00
Open 381.20 High 385.98 Low 376.83 Prev Close 375.72
Last Trade Volume 601,227 52 Wk Hi 416.49 52 Wk Low 281.89
Market Cap 40.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 108,234,564.00 EPS (TTM) 15.65 PE Ratio 23.80 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 10 130
Number of Buys 2 21
Number of Sells 8 109
Net Activity -20000 -71130
Last 10 Buys Shares
Christine A. Poon 1,000
Christine A. Poon 1,000
Arthur Frederick Ryan 1,000
George L. Sing 1,000
George L. Sing 1,000
George L. Sing 1,000
George L. Sing 1,000
George L. Sing 1,000
Last 10 Sell Shares
Neil Stahl 1,000
George L. Sing 1,000
George L. Sing 1,000
George L. Sing 1,000
George L. Sing 1,000
George L. Sing 1,000
Joseph L. Goldstein 1,000
Joseph L. Goldstein 1,000
Joseph L. Goldstein 1,000
Michael S. Brown 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 540 540 540 540
Low Target Price Estimate 303 303 303 303
Mean Target Price Estimate 403.29 403.29 403.29 403.29
Standard Deviation 63.28 63.28 63.28 63.28
Date of Most Recent Estimate 06/01/18 05/08/18 05/08/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 8 8
Moderate Buy 0 0 0 1
Hold 15 15 15 14
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.48 2.48 2.42 2.38